V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 290005457 | 290003974 | 1.5 | 53.6 | Curative (C) | 2014-08-15 | 2014-09-11 | LANREOTIDE | N | N | 290016172 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 290005458 | 290003975 | 1.6 | 80.8 | Palliative (P) | 2017-02-25 | 2017-02-25 | Cetuximab + Radiotherapy Load | 02 | N | 290016531 | FLUOROURACIL |
| 290005459 | 290003975 | 1.51 | null | Curative (C) | null | 2017-09-14 | Cisplatin + Docetaxel +Fluorouracil | N | Y | 290016531 | BLEOMYCIN |
| 290005460 | 290003976 | null | 110 | Adjuvant (A) | 2016-05-06 | 2016-05-27 | Capecitabine 35days + RT | 02 | N | 290016616 | CAPECITABINE + TEMOZOLOMIDE |
| 290005461 | 290003977 | 1.84 | null | null | 2014-02-13 | 2014-02-26 | OCTREOTIDE | 2 | N | 290016674 | CISPLATIN + FLUOROURACIL |
| 290005462 | 290003978 | 1.76 | 87.4 | Palliative (P) | 2017-01-11 | 2017-01-20 | ECX | Y | Y | 290016843 | CISPLATIN + FLUOROURACIL |
| 290005463 | 290006683 | 1.55 | 86.9 | Palliative (P) | 2017-05-30 | 2017-06-10 | EOX | N | N | 290016845 | CAPECITABINE + RT |
| 290005464 | 290006683 | 1.8 | 57.8 | Neo-adjuvant (N) | 2018-05-18 | 2018-05-22 | CAPECITABINE + RT | N | N | 290016845 | CISPLATIN + FLUOROURACIL |
| 290005465 | 290006683 | 1.47 | 0 | Adjuvant (A) | 2015-01-23 | 2015-02-14 | OCTREOTIDE | Y | N | 290016845 | CISPLATIN + VINORELBINE |
| 290005466 | 290003979 | null | 84 | null | 2015-01-11 | 2015-01-11 | LANREOTIDE | N | null | 290017011 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 290005467 | 290003979 | 1.63 | 67.8 | Palliative (P) | null | 2017-03-24 | Cisplatin + Docetaxel +Fluorouracil | N | N | 290017011 | CTD |
| 290005468 | 290003980 | 1.57 | 78.8 | Palliative (P) | 2019-03-30 | 2019-03-30 | CARBOPLATIN + ETOPOSIDE | N | N | 290017317 | CETUXIMAB + CISPLATIN + FU |
| 290005469 | 290003981 | 1.77 | 79 | Curative (C) | 2018-04-20 | 2018-06-14 | FLUOROURACIL | N | Y | 290017352 | PEMBROLIZUMAB |
| 290005470 | 290003981 | 1.58 | 52 | Palliative (P) | 2018-02-14 | 2018-02-14 | Fluorouracil + Folinic Acid Weekly | N | N | 290017352 | CARBOPLATIN |
| 290005471 | 290003982 | 1.55 | 68.6 | null | null | 2016-11-07 | Capecitabine (21days) + Carboplatin | N | N | 290017365 | CAPE + CARBOPLATIN + CETUXIMAB |
| 290005472 | 290003983 | 1.7 | 0 | Adjuvant (A) | 2013-06-03 | 2013-06-16 | Capecitabine | N | N | 290017510 | CHOP R |
| 290005473 | 290006686 | null | null | Curative (C) | 2015-09-24 | 2015-10-17 | EOX | null | Y | 290017563 | CISPLATIN + FLUOROURACIL |
| 290005474 | 290003984 | null | null | Curative (C) | 2016-03-08 | 2016-03-08 | OCTREOTIDE | 02 | Y | 290017666 | LANREOTIDE |
| 290005475 | 290003984 | 1.84 | 104.6 | Palliative (P) | 2016-04-29 | 2016-04-29 | CISPLATIN + ETOPOSIDE | 02 | N | 290017666 | CAPECITABINE + TEMOZOLOMIDE |
| 290005476 | 290003985 | 0 | 80 | Neo-adjuvant (N) | 2016-06-10 | 2016-06-21 | CTD | N | N | 290017726 | CISPLATIN + FLUOROURACIL |
| 290005477 | 290003985 | 1.8 | 73 | Palliative (P) | 2016-09-30 | 2016-10-26 | LANREOTIDE | N | N | 290017726 | CVD |
| 290005480 | 290003986 | 1.83 | 58.7 | Palliative (P) | 2014-03-08 | 2014-08-22 | OCTREOTIDE | N | N | 290017968 | TRIAL |
| 290005481 | 290003987 | null | 79 | Curative (C) | 2016-09-04 | 2016-09-29 | LANREOTIDE | 02 | Y | 290018114 | CAPECITABINE + RT |
| 290005482 | 290003988 | 1.51 | 54.45 | Curative (C) | 2016-01-27 | 2016-02-07 | Capecitabine | N | Y | 290018262 | OCTREOTIDE |
| 290005483 | 290003989 | 1.82 | 72 | Palliative (P) | 2018-09-15 | 2018-09-29 | Cetuximab 7 day (>Cycle 2) | 02 | null | 290018263 | CISPLATIN + FLUOROURACIL |
| 290005484 | 290003990 | null | null | Adjuvant (A) | null | 2013-07-05 | Capecitabine 35days + RT | N | N | 290018274 | RITUXIMAB |
| 290005485 | 290003991 | 1.62 | 96 | Disease modification (D) | 2015-12-10 | 2015-12-16 | Carboplatin AUC 2 - 5 | N | N | 290018352 | CISPLATIN + FLUOROURACIL |
| 290005486 | 290003992 | 1.64 | null | Neo-adjuvant (N) | 2017-12-29 | 2018-01-17 | Carbo F | Y | Y | 290018375 | CETUXIMAB + RT |
| 290005487 | 290003993 | 1.79 | null | Curative (C) | 2013-10-07 | 2013-10-25 | Docetaxel 75mg/m2 (21 day) | N | Y | 290018443 | CAPECITABINE + RT |
| 290005488 | 290003993 | 0 | 58.7 | null | 2017-06-27 | 2017-07-25 | ECX | N | N | 290018443 | CISPLATIN + FLUOROURACIL |
| 290005489 | 290007814 | 1.61 | 58 | Curative (C) | 2017-08-27 | 2017-09-01 | Capecitabine 35days + RT | null | Y | 290018581 | CARBOPLATIN + ETOPOSIDE |
| 290005490 | 290007814 | 1.65 | null | Curative (C) | 2016-12-31 | 2017-01-11 | OCTREOTIDE | 02 | N | 290018581 | CAPECITABINE |
| 290005491 | 290007814 | 1.6 | 68.8 | Palliative (P) | 2016-09-04 | 2016-09-10 | Capecitabine 35days + RT | N | N | 290018581 | MITOMYCIN INTRAVESICULAR |
| 290005492 | 290007814 | 1.67 | 86 | Adjuvant (A) | 2016-04-24 | 2016-04-28 | Capecitabine | N | N | 290018581 | CETUXIMAB |
| 290005493 | 290007814 | 1.71 | null | Adjuvant (A) | 2014-09-26 | 2014-10-04 | IPILIMUMAB + NIVOLUMAB | 02 | N | 290018581 | CARBOPLATIN |
| 290005494 | 290007814 | 1.87 | 47 | null | 2016-10-16 | 2016-11-16 | BALLAD Trial | 02 | N | 290018581 | CAPECITABINE |
| 290005495 | 290007814 | 1.64 | 62.8 | Neo-adjuvant (N) | 2017-07-19 | 2017-08-18 | Trial Unspecified | N | N | 290018581 | CAPECITABINE |
| 290005496 | 290003994 | 1.88 | 89.6 | null | 2013-06-08 | 2013-06-24 | Cisplatin +Fluorouracil (3 wk) | 02 | N | 290018872 | CAPECITABINE + RT |
| 290005497 | 290003995 | 1.64 | 78 | Neo-adjuvant (N) | 2018-08-26 | 2018-09-05 | Paclitaxel 7 day | 02 | N | 290018883 | IPILIMUMAB + NIVOLUMAB |
| 290005498 | 290006690 | null | 60.2 | Curative (C) | 2017-07-25 | 2017-05-04 | Ipilimumab | null | N | 290019430 | CARBOPLATIN |
| 290005499 | 290003996 | 1.62 | 72.7 | Disease modification (D) | 2018-03-13 | 2018-04-03 | MITOMYCIN | N | N | 290019493 | TRIAL |
| 290005500 | 290003997 | 1.61 | 81 | null | 2014-06-19 | 2014-06-21 | Cyclophosphamide + Docetaxel | 2 | null | 290019536 | CAPECITABINE |
| 290005501 | 290003998 | 1.69 | 65 | null | 2018-05-26 | 2018-05-26 | Capecitabine | 02 | null | 290019538 | MITOMYCIN |
| 290005502 | 290006691 | 1.86 | 65.5 | Palliative (P) | 2017-11-21 | 2017-11-28 | Bevacizumab 5mg/kg | 02 | N | 290019567 | CISPLATIN + FLUOROURACIL |
| 290005503 | 290003999 | 1.7 | 66.4 | Adjuvant (A) | 2018-03-28 | 2018-04-10 | CARBOPLATIN + DOCETAXEL + FLUOROURACIL | null | N | 290019677 | GEMCITABINE |
| 290005504 | 290004000 | 1.59 | 48.6 | Neo-adjuvant (N) | 2017-10-11 | 2017-10-25 | Capecitabine 35days + RT | N | N | 290019745 | CARBOPLATIN + ETOPOSIDE |
| 290005505 | 290004001 | 1.67 | 65 | null | 2018-04-17 | 2018-04-27 | Capecitabine | N | N | 290019747 | CAPECITABINE + RT |
| 290005506 | 290004001 | 1.55 | 58 | Neo-adjuvant (N) | 2018-03-14 | 2018-03-27 | MITOMYCIN | N | N | 290019747 | CAPECITABINE + RT |
| 290005507 | 290004001 | 1.6 | 76 | Palliative (P) | 2015-11-10 | 2015-11-16 | CARBOPLATIN + ETOPOSIDE | 02 | N | 290019747 | FLUOROURACIL |
| 290005508 | 290004002 | 1.66 | 48.6 | Palliative (P) | 2018-11-02 | 2018-11-02 | Carboplatin AUC 2 - 5 | 2 | N | 290020131 | CARBOPLATIN + DOCETAXEL + FLUOROURACIL |